"DABIGATREX 150: Dabigatran Etexilate (150mg) for Stroke Prevention"

DABIGATREX 150 

Dabigatran Etexilate (150mg)

Introduction to Dabigatran Etexilate (150mg)

DABIGATREX 150, containing Dabigatran Etexilate (150mg), is a powerful anticoagulant medication designed to prevent and treat blood clots. It is especially effective in reducing the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation. It is also prescribed for the treatment and prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE).

How DABIGATREX 150 Works

Dabigatran Etexilate is a direct thrombin inhibitor. Thrombin is an enzyme essential for blood clot formation. By inhibiting thrombin, Dabigatran Etexilate prevents the formation of clots, thereby reducing the risk of stroke, DVT, and PE.

Uses of Dabigatran Etexilate (150mg)

DABIGATREX 150 is primarily used for:

• Reducing the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation
• Treating deep vein thrombosis (DVT) and pulmonary embolism (PE)
• Preventing recurrent DVT and PE

Dosage and Administration

The typical dosage of DABIGATREX 150 is one capsule taken twice daily. It is important to take the medication as prescribed by the healthcare provider. Consistency in taking the medication at the same times each day ensures optimal results and reduces the risk of complications.

Potential Side Effects

While DABIGATREX 150 is generally well-tolerated, some patients may experience side effects, including:

• Bleeding or bruising
• Indigestion or stomach discomfort
• Gastrointestinal bleeding
• Anemia
• Nausea

Precautions and Warnings

Before starting DABIGATREX 150, patients should inform their healthcare provider about any existing medical conditions, particularly:

• Kidney or liver disease
• A history of bleeding disorders
• Recent surgery or injury
• Allergies to Dabigatran Etexilate or any other medications

Pregnant or breastfeeding women should consult their healthcare provider before using DABIGATREX 150 due to potential risks to the fetus or infant.

Conclusion

DABIGATREX 150, containing Dabigatran Etexilate (150mg), offers significant benefits for reducing the risk of stroke and blood clots in patients with atrial fibrillation and for treating and preventing DVT and PE. Always consult with a healthcare provider for personalized advice and treatment plans to ensure the safe and effective use of this medication.Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. This company, which is based in Navi Mumbai, holds certifications from WHO, GMP, and ISO. Its commitment is to provide high-quality drugs at affordable prices to its customers throughout India, following the rigorous guidelines set by the WHO. Steris offers the convenience of an online pharmacy where customers can easily buy medicines and enjoy the benefit of home delivery. At Steris, the mission is to supply a wide array of healthcare products designed to meet the varied needs of the medical community. Whether it is advanced treatments, medications for rare conditions, or basic health necessities, Sterispharma strives to serve the healthcare industry’s broad demands. The extensive product lineup from Steris includes treatments for various health areas such as Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

  For further information: 

 EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

 CALL/WHATSAPP: 7877551268, 7849827488

   BUY NOW